HuagongsheHuagongshe Chemistry Print Report · For research reference only
5-Aminoimidazole-4-carboxamide → Temozolomide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 5-Aminoimidazole-4-carboxamide | HCID 9679 | — |
| Reactant | Methyl Isocyanate | HCID 12228 | — |
| Reactant | 5-diazo-1H-imidazole-4-carboxamide | HCID 136377446 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | Temozolomide | HCID 5394 | — |
Reaction Steps
In this process, 5-amino-1H-imidazole-4-carboxamide (A) is converted into 5-diazo-1H-imidazole-4-carboxamide (B), which is then cyclized with methylisocyanate in dichloromethane to provide a high yield of clinical-grade Temozolomide. However, this process requires isolation of the unstable and potentially dangerous 5-diazo-1H-imidazole-4-carboxamide (B). Moreover, methylisocyanate is a difficult reagent to handle and ship, especially on the industrial scale, and indeed is better avoided in industrial manufacture. Furthermore, the cycloaddition of methylisocyanate requires a very long reaction time: Table I in J. Med. Chem. 1984, 27, 196-201, suggests 20 days.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07446209B2 |
| Source dataset | uspto-grants-2008_11 |
| ORD ID | ord-956324603b68473d96417d19794af44e |
| Source note | uspto-grants-2008_11 |